Tobramycin Antibiotic Market - Inhaled Formulation Innovation...

ha aggiunto una foto Health

2026-07-11 17:27:31 -

Tobramycin Antibiotic Market - Inhaled Formulation Innovation Targeting Cystic Fibrosis and Resistant Infections

Market Overview The tobramycin antibiotic market is advancing as inhaled formulation innovation targets cystic fibrosis and multidrug-resistant infections with improved safety profiles. The Tobramycin Antibiotic Market is projected to grow from USD 741 million in 2026, driven by cystic fibrosis prevalence, hospital-acquired infection burden, and targeted delivery technology reducing systemic...

0 Commenti 0 condivisioni 3 Views 0 Anteprima